Man Group’s Clover Health Investments CLOV Stock Holding History

Man Group’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-43,475	Closed	-$121K	–	2251
2025 Q2	$121K	Buy	43,475 +14,602	+51%	+$48K	﹤0.01%	2112
2025 Q1	$104K	Buy	+28,873	New	+$116K	﹤0.01%	2109
2024 Q1	–	Sell	-30,872	Closed	-$29.4K	–	2134
2023 Q4	$29.4K	Buy	+30,872	New	+$30.3K	﹤0.01%	2015
2023 Q3	–	Hold	0	–	–	–	1858
2023 Q1	–	Sell	-16,171	Closed	-$15K	–	2100
2022 Q4	$15K	Sell	16,171 -303,923	-95%	-$406K	﹤0.01%	1977
2022 Q3	$544K	Buy	+320,094	New	+$838K	﹤0.01%	1489
2022 Q2	–	Sell	-149,416	Closed	-$397K	–	1570
2022 Q1	$530K	Sell	149,416 -14,499	-9%	-$42K	﹤0.01%	1565
2021 Q4	$610K	Buy	+163,915	New	+$1.01M	﹤0.01%	1475

Other funds holding CLOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Man Group's CLOV Position: Q3 2025 in Review

Man Group sold out of Clover Health Investments (CLOV) in Q3 2025, closing a stake of 43,475 shares — an estimated $121K sold.

Man Group first reported a position in CLOV in Q4 2021 and held it in 7 quarters. The position peaked at $610K in Q4 2021. 201 funds tracked by Wall St. Rank hold CLOV as of Q3 2025.

Man Group reported no remaining Clover Health Investments position as of Q3 2025 after selling out during the quarter.
Man Group sold 43,475 Clover Health Investments shares in Q3 2025, an estimated $121K.
Man Group first reported a position in Clover Health Investments in Q4 2021 and held it in 7 quarters.
Man Group's Clover Health Investments position peaked at $610K in Q4 2021.
201 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.